arrow
R

Rammurti T. Kamble

ut md anderson cancer center
H指数:52
被引数:9,763

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparison of Fludarabine Versus Bendamustine as a Lymphodepleting Chemotherapy Prior to CAR-T for Large Cell Lymphoma

与贝antasine相比,氟达拉滨作为大细胞淋巴瘤CAR-T治疗前淋巴清除化疗的比较

2026-06-240
PREAI
Late effects after allogeneic haematopoietic cell transplantation in children and adolescents with nonmalignant disorders: a retrospective cohort study
2024-10-011
PRE
Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis

移植后环磷酰胺与常规GvHD预防后移植物抗宿主病 (GvHD) 的特征

2022-10-0121
OAAI
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma

三联疗法,移植和维持直到骨髓瘤进展

2022-07-14241
OA
Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Research
2022-04-0110
OAAI
Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia

单倍体与同胞,无关或脐带血造血细胞移植治疗急性淋巴细胞白血病

2022-01-1148
OAAI
Bortezomib-Based Induction Is Associated with Superior Outcomes in Light Chain Amyloidosis Patients Treated with Autologous Hematopoietic Cell Transplantation Regardless of Plasma Cell Burden
2021-03-0114
OAAI
Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States

美国异基因造血干细胞移植后的社区健康状况和结局

CANCER
IF5.1
2020-10-2113
OAAI
Comparison of outcomes of HCT in blast phase of BCR-ABL1- MPN with de novo AML and with AML following MDS
2020-10-0218
OAAI
African Americans with translocation t(11;14) have superior survival after autologous hematopoietic cell transplantation for multiple myeloma in comparison with Whites in the United States
CANCER
IF5.1
2020-09-2320
OAAI
The safety and clinical effects of administering a multiantigen-targeted T cell therapy to patients with multiple myeloma
2020-07-2928
PREAI
Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases
2020-05-1221
OAAI
Weighty choices: selecting optimal G-CSF doses for stem cell mobilization to optimize yield
2020-02-2411
OA
Outcomes of Rituximab-BEAM Versus BEAM Conditioning Regimen in Patients With Diffuse Large B Cell Lymphoma Undergoing Autologous Transplantation

利妥昔单抗-BEAM与BEAM预处理方案在弥漫性大b细胞淋巴瘤患者自体移植中的疗效比较

CANCER
IF5.1
2020-02-1219
OAAI